Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 09-Nov-2022 titled Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US
Sun Pharmaceutical Industries Limited has informed the Exchange about press release dated 09-Nov-2022 titled Sun Pharma and SPARC enter into a license agreement for commercialization of phenobarbital for injection in the US